Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Aims: Obesity is a significant problem for patients taking atypical antipsychotics. There were two aims of our study. The first aim was to compare the prevalence of overweight and obesity between children and adolescents with autism spectrum disorder (ASD) treated with risperidone with the general p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Vanwong, Natchaya, Ngamsamut, Nattawat, Nuntamool, Nopphadol, Hongkaew, Yaowaluck, Sukprasong, Rattanaporn, Puangpetch, Apichaya, Limsila, Penkhae, Sukasem, Chonlaphat
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677569/
https://ncbi.nlm.nih.gov/pubmed/33240086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.565074
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky